Department of Quality, WVU Medicine: United Hospital Center, Bridgeport, WV.
Am J Med Qual. 2022;37(5):405-412. doi: 10.1097/JMQ.0000000000000055. Epub 2022 Mar 30.
A West Virginia regional community hospital incorporated an initial specimen diversion device (ISDD) into conventional blood culture protocol with the objective to bring the hospital-wide blood culture contamination (BCC) rate from a 3.06% preintervention rate to a target performance level below 1%. Emergency department staff, laboratory phlebotomists, and nursing staff on acute-critical care floors were trained on ISDD (Steripath Gen2, Magnolia Medical Technologies, Inc., Seattle, WA) operating procedure and utilized the device for blood culture sample collection with adult patients from September 2020 through April 2021. Of 5642 blood culture sets collected hospital-wide, 4631 were collected with the ISDD, whereas the remaining sets were collected via the conventional method. The ISDD BCC rate of 0.78% differed from the conventional method BCC rate of 4.06% observed during the intervention period (chi-squared test P < 0.00001). The ISDD group attained a sub-1% BCC rate to satisfy the intervention objective.
一家位于西弗吉尼亚州的地区社区医院将初始标本分流装置（ISDD）纳入常规血培养方案中，目的是将医院范围内的血培养污染（BCC）率从干预前的 3.06%降低到目标性能水平以下 1%。急诊部工作人员、实验室采血员和急性重症监护病房的护理人员接受了 ISDD（Steripath Gen2，Magnolia Medical Technologies，Inc.，西雅图，WA）操作程序的培训，并在 2020 年 9 月至 2021 年 4 月期间使用该设备为成年患者采集血培养样本。在全院采集的 5642 份血培养集中，有 4631 份是用 ISDD 采集的，其余的是用常规方法采集的。ISDD 的 BCC 率为 0.78%，与干预期间观察到的常规方法 BCC 率 4.06%不同（卡方检验 P < 0.00001）。ISDD 组达到了低于 1%的 BCC 率，满足了干预目标。
